{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T17:19:30Z","timestamp":1789924770768,"version":"4.0.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004607","name":"Guangxi Natural Science Foundation","doi-asserted-by":"publisher","award":["2014GXNSFAA118262"],"award-info":[{"award-number":["2014GXNSFAA118262"]}],"id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guangxi Committee of Science and Technology","award":["Z2007084"],"award-info":[{"award-number":["Z2007084"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.imlet.2016.02.005","type":"journal-article","created":{"date-parts":[[2016,2,12]],"date-time":"2016-02-12T14:16:24Z","timestamp":1455286584000},"page":"47-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Altered expression of miR-125a-5p in thymoma-associated myasthenia gravis and its down-regulation of foxp3 expression in Jurkat cells"],"prefix":"10.1016","volume":"172","author":[{"given":"Jinpin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zezhi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuean","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2016.02.005_bib0005","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1172\/JCI29894","article-title":"Myasthenia gravis: past, present, and future","volume":"116","author":"Conti-Fine","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imlet.2016.02.005_bib0010","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/WCO.0b013e328357a829","article-title":"Autoimmune mechanisms in myasthenia gravis","volume":"25","author":"Cavalcante","year":"2012","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.imlet.2016.02.005_bib0015","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3109\/08916930903555935","article-title":"Thymoma and paraneoplastic myasthenia gravis","volume":"43","author":"Marx","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.imlet.2016.02.005_bib0020","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.autrev.2013.03.010","article-title":"Etiology of myasthenia gravis: innate immunity signature in pathological thymus","volume":"12","author":"Cavalcante","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.imlet.2016.02.005_bib0025","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jns.2011.09.037","article-title":"Different molecular expression in thymoma with ocular or generalized myasthenia gravis","volume":"313","author":"Zhang","year":"2012","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.imlet.2016.02.005_bib0030","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1196\/annals.1405.018","article-title":"Common cellular and diverse genetic basis of thymoma-associated myasthenia gravis: role of MHC class II and AIRE genes and genetic polymorphisms","volume":"1132","author":"Strobel","year":"2008","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.imlet.2016.02.005_bib0035","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0002-9440(10)64536-1","article-title":"Recurrent genetic aberrations in thymoma and thymic carcinoma","volume":"157","author":"Zettl","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.imlet.2016.02.005_bib0040","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/JTO.0b013e3181a4b8e0","article-title":"The management of thymoma: a systematic review and practice guideline","volume":"4","author":"Falkson","year":"2009","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.imlet.2016.02.005_bib0045","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.hoc.2008.03.004","article-title":"Thymoma myasthenia gravis, and other paraneoplastic syndromes","volume":"22","author":"Tormoehlen","year":"2008","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.imlet.2016.02.005_bib0050","doi-asserted-by":"crossref","first-page":"S266","DOI":"10.1097\/JTO.0b013e3181f1f63f","article-title":"The autoimmune regulator AIRE in thymoma biology: autoimmunity and beyond","volume":"5","author":"Marx","year":"2010","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.imlet.2016.02.005_bib0055","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nrg2290","article-title":"Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?","volume":"9","author":"Filipowicz","year":"2008","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.imlet.2016.02.005_bib0060","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.cell.2006.07.031","article-title":"A pattern-based method for the identification of microRNA binding sites and their corresponding heteroduplexes","volume":"126","author":"Miranda","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.imlet.2016.02.005_bib0065","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.imlet.2016.02.005_bib0070","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s00109-013-1043-z","article-title":"MicroRNA in immunity and autoimmunity","volume":"91","author":"Zhu","year":"2013","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.imlet.2016.02.005_bib0075","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/nrm2632","article-title":"Biogenesis of small RNAs in animals","volume":"10","author":"Kim","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.imlet.2016.02.005_bib0080","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00018-007-7355-9","article-title":"Functional aspects of animal microRNAs","volume":"65","author":"Williams","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.imlet.2016.02.005_bib0085","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cell.2005.01.014","article-title":"RAS is regulated by the let-7 microRNA family","volume":"120","author":"Johnson","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.imlet.2016.02.005_bib0090","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1002\/art.23429","article-title":"Expression of microRNA-146 in rheumatoid arthritis synovial tissue","volume":"58","author":"Nakasa","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2016.02.005_bib0095","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s10875-012-9834-5","article-title":"MiR-320a is downregulated in patients with myasthenia gravis and modulates inflammatory cytokines production by targeting mitogen-activated protein kinase 1","volume":"33","author":"Cheng","year":"2013","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.imlet.2016.02.005_bib0100","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.intimp.2012.07.003","article-title":"Altered let-7 expression in Myasthenia gravis and let-7c mediated regulation of IL-10 by directly targeting IL-10 in Jurkat cells","volume":"14","author":"Jiang","year":"2012","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.imlet.2016.02.005_bib0105","doi-asserted-by":"crossref","first-page":"12481","DOI":"10.1073\/pnas.0605298103","article-title":"NF-\u03baB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses","volume":"103","author":"Taganov","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imlet.2016.02.005_bib0110","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1172\/JCI33099","article-title":"MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets","volume":"117","author":"van Rooij","year":"2007","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.imlet.2016.02.005_bib0115","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/15384047.2015.1108493","article-title":"Circulating miR-21-5p and miR-148a-3p as emerging non-invasive biomarkers in thymic epithelial tumors","volume":"17","author":"Bellissimo","year":"2016","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.imlet.2016.02.005_bib0120","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.3892\/mmr.2014.2567","article-title":"Reduced miR-125a-5p expression is associated with gastric carcinogenesis through the targeting of E2F3","volume":"10","author":"Xu","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.imlet.2016.02.005_bib0125","doi-asserted-by":"crossref","first-page":"e69118","DOI":"10.1371\/journal.pone.0069118","article-title":"Comprehensive microRNA analysis identifies miR-24 and miR-125a-5p as plasma biomarkers for rheumatoid arthritis","volume":"8","author":"Murata","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.imlet.2016.02.005_bib0130","doi-asserted-by":"crossref","first-page":"6857","DOI":"10.1523\/JNEUROSCI.3965-12.2013","article-title":"MicroRNAs regulate human brain endothelial cell-barrier function in inflammation: implications for multiple sclerosis","volume":"33","author":"Reijerkerk","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.imlet.2016.02.005_bib0135","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3109\/01902148.2010.492068","article-title":"MicroRNA HSA-miR-125a-5p induces apoptosis by activating p53 in lung cancer cells","volume":"37","author":"Jiang","year":"2011","journal-title":"Exp. Lung Res."},{"key":"10.1016\/j.imlet.2016.02.005_bib0140","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/cvr\/cvp121","article-title":"MicroRNA-125a-5p partly regulates the inflammatory response, lipid uptake, and ORP9 expression in oxLDL-stimulated monocyte\/macrophages","volume":"83","author":"Chen","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.imlet.2016.02.005_bib0145","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.imlet.2016.02.005_bib0150","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.imlet.2008.11.015","article-title":"The role of foxp3+CD4+CD25hi tregs in the pathogenesis of myasthenia gravis","volume":"122","author":"Zhang","year":"2009","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.imlet.2016.02.005_bib0155","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.imlet.2014.04.008","article-title":"Autoimmune regulator expression in thymomas with or without autoimmune disease","volume":"161","author":"Liu","year":"2014","journal-title":"Immunol. Lett."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247816300141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247816300141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T10:17:03Z","timestamp":1567592223000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247816300141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":31,"alternative-id":["S0165247816300141"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2016.02.005","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered expression of miR-125a-5p in thymoma-associated myasthenia gravis and its down-regulation of foxp3 expression in Jurkat cells","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2016.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}